<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tavares AH</submitter><funding>National Institute of Diabetes and Digestive and Kidney Diseases</funding><funding>NIDDK NIH HHS</funding><funding>National Institutes of Health</funding><funding>Boston Nutrition Obesity Research Center, Boston University</funding><pagination>110563</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12423405</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>301(9)</volume><pubmed_abstract>White adipose tissue (WAT) fibrosis is a major determinant of obesity-induced cardiometabolic dysfunction and is characterized by excessive extracellular matrix deposition and myofibroblast activation. Transforming growth factor (TGF)-β1 is a profibrotic cytokine that potently induces myofibroblast activation in adipocyte stem cells (ASCs). How TGF-β1 orchestrates ASC activation in WAT fibrosis is not completely understood. We identified FOXS1, a member of the forkhead box transcription factor superfamily, as a transcriptional target of TGF-β1 signaling in primary human WAT ASC (hASC). FOXS1 potentiated TGF-β1-dependent upregulation of several myofibroblast genes (e.g. Acta2, Col1a1, Fn1, and Il11) in 10T1/2 fibroblasts. FOXS1 also attenuated the induction of several adipogenic factors (e.</pubmed_abstract><journal>The Journal of biological chemistry</journal><pubmed_title>TGF-β1-dependent expression of FOXS1 attenuates adipogenic potential and enhances a myofibroblast cellular phenotype.</pubmed_title><pmcid>PMC12423405</pmcid><funding_grant_id>P30 DK046200</funding_grant_id><funding_grant_id>R01DK132080</funding_grant_id><funding_grant_id>P30DK046200</funding_grant_id><funding_grant_id>R01 DK134534</funding_grant_id><funding_grant_id>T32DK007201</funding_grant_id><funding_grant_id>R01 DK132080</funding_grant_id><funding_grant_id>T32 DK007201</funding_grant_id><funding_grant_id>R01DK134534</funding_grant_id><pubmed_authors>Layne MD</pubmed_authors><pubmed_authors>Zheng J</pubmed_authors><pubmed_authors>Tavares AH</pubmed_authors><pubmed_authors>Rabhi N</pubmed_authors><pubmed_authors>Connelly SP</pubmed_authors><pubmed_authors>Maksat D</pubmed_authors></additional><is_claimable>false</is_claimable><name>TGF-β1-dependent expression of FOXS1 attenuates adipogenic potential and enhances a myofibroblast cellular phenotype.</name><description>White adipose tissue (WAT) fibrosis is a major determinant of obesity-induced cardiometabolic dysfunction and is characterized by excessive extracellular matrix deposition and myofibroblast activation. Transforming growth factor (TGF)-β1 is a profibrotic cytokine that potently induces myofibroblast activation in adipocyte stem cells (ASCs). How TGF-β1 orchestrates ASC activation in WAT fibrosis is not completely understood. We identified FOXS1, a member of the forkhead box transcription factor superfamily, as a transcriptional target of TGF-β1 signaling in primary human WAT ASC (hASC). FOXS1 potentiated TGF-β1-dependent upregulation of several myofibroblast genes (e.g. Acta2, Col1a1, Fn1, and Il11) in 10T1/2 fibroblasts. FOXS1 also attenuated the induction of several adipogenic factors (e.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-06-03T02:51:36.712Z</modification><creation>2026-04-23T03:11:57.747Z</creation></dates><accession>S-EPMC12423405</accession><cross_references><pubmed>40774386</pubmed><doi>10.1016/j.jbc.2025.110563</doi></cross_references></HashMap>